Your browser doesn't support javascript.
loading
Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms.
King, Amber C; Weis, Taylor M; Derkach, Andriy; Ball, Somedeb; Pandey, Manu; Mauro, Michael J; Goldberg, Aaron D; Stahl, Maximilian; Famulare, Christopher; Tallman, Martin S; Wang, Eunice S; Kuykendall, Andrew T; Rampal, Raajit K.
Afiliación
  • King AC; Department of Pharmacy, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Weis TM; Department of Pharmacy, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Derkach A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Ball S; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida, USA.
  • Pandey M; Department of Medicine, Leukemia Service, Roswell Park Cancer Center, Buffalo, New York, USA.
  • Mauro MJ; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Goldberg AD; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Stahl M; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Famulare C; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Tallman MS; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Wang ES; Department of Medicine, Leukemia Service, Roswell Park Cancer Center, Buffalo, New York, USA.
  • Kuykendall AT; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida, USA.
  • Rampal RK; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Am J Hematol ; 97(1): E7-E10, 2022 01 01.
Article en En | MEDLINE | ID: mdl-34674293

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Compuestos Bicíclicos Heterocíclicos con Puentes / Trastornos Mieloproliferativos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Compuestos Bicíclicos Heterocíclicos con Puentes / Trastornos Mieloproliferativos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos